NTHRYS › Internships › Ai Cancer Biology › AI Drug Resistance Mechanism Discovery Research

Epigenetic Remodeling and Chromatin Accessibility in Resistant Phenotypes

Ai Cancer Biology

AI Drug Resistance Mechanism Discovery Research

Variant

Pay · Join

Step 4 of 5Select variant

Field

▾

Category

▾

Focused area

▾

You might prefer

Transcriptomic Profiling of Drug-Resistant Cancer Cell Populations Proteomic Analysis of Altered Signaling Pathway Activation Mechanisms Single-Cell Heterogeneity Mapping in Chemotherapy Response Variation Machine Learning Models Predicting Acquired Resistance Trajectories Spatial Transcriptomics of Tumor Microenvironment Contributing to Resistance Metabolic Reprogramming Associated with Multi-Drug Resistance Phenotypes Extracellular Vesicle-Mediated Communication Networks in Resistance Propagation Mutational Landscape Evolution During Long-Term Drug Selection Pressure Artificial Intelligence-Driven Target Identification for Resistance-Dependent Vulnerabilities

Ai Cancer Biology › AI Drug Resistance Mechanism Discovery Research

Epigenetic Remodeling and Chromatin Accessibility in Resistant Phenotypes

This research examines DNA methylation patterns, histone modifications, and chromatin accessibility changes using ATAC-seq and ChIP-seq in drug-resistant cancer populations. The study uncovers epigenetic mechanisms that silence drug sensitivity genes and activate survival pathways independent of genetic mutations.

🎓 TYPE

🌐 MODE

⏱

📚 Academic: Thesis & PPT assistance included🧪 Tech: Master the protocols hands-on📝 Research > 3 months: Publication co-authorship in a Scopus-indexed journal

Select your preferenceChoose Type, Mode, Duration to view Titles

Internship Type

Mode

Duration

🎯

Choose your preferences above

Select Type, Mode and Duration to view available internship titles and fees.